These data suggest that the risk of coronary artery disease, CRC, and OVCF, which can reflect and be linked to underlying metabolic diseases (e.g., DM, HTN, and folate), may be further modulated by the PAI-1, genotype leading to a much higher risk of disease. This evidence concerns the gene SERPINE1 and metabolic disease.